Quantcast

Latest Relmada Therapeutics Inc. Stories

2014-09-16 08:29:45

Results Validating the Multi-Modal Mechanism of Action Would Provide the Basis for Differentiating LevoCap ER from other Pain Therapies NEW YORK, Sept. 16, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has entered into an agreement with Memorial Sloan Kettering Cancer Center (MSKCC) in a series of animal studies for levorphanol, the active ingredient of...

2014-09-10 08:30:33

Key Step Accomplished Signals the Initiation of Clinical Development for Potential Blockbuster d-methadone NEW YORK, Sept. 10, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc. (OTCBB: RLMD) ("Relmada" or the "Company"), a clinical stage company developing novel therapies for the treatment of chronic pain, today announced that it has filed a Clinical Trial Application (CTA) with Heath Canada to conduct 2 pharmacokinetic studies with d-methadone, its NMDA receptor antagonist for...

2014-09-09 08:31:52

Material Progress on All Fronts in 2014 Leave Company Strongly Positioned to Unlock the Value of its Robust Pain Product Pipeline NEW YORK, Sept. 9, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a Nevada corporation (the "Company") developing novel therapies for the treatment of chronic pain, today announced that is has filed its Form 10-K with the SEC, showing the Company's significant strides in 2014. The Company has made significant progress scientifically, financially...

2014-09-03 08:33:17

CEO to Provide Update on the Recent Progress of the Company and Outlook for Chronic Pain Pipeline NEW YORK, Sept. 3, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), today announced it will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2014, at The Palace Hotel in New York City. Sergio...

2014-08-06 12:28:33

The Company's New Ticker Is RLMD NEW YORK, Aug. 6, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a Nevada corporation (the "Company"), a clinical-stage company developing novel therapies for the treatment of chronic pain is pleased to announce that Financial Industry Regulatory Authority (FINRA) has approved the Company's application for a name change from Camp Nine, Inc. to Relmada Therapeutics, Inc. and assigned a new trading symbol, RLMD. The Company also...

2014-07-09 08:27:41

Name Change to Reflect the Operations of the Company after the Completion of the Public Transaction NEW YORK, July 9, 2014 /PRNewswire/ -- Camp Nine, Inc., (OTCBB: CMPE), a Nevada corporation which conducts its operations through Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has changed its corporate name to Relmada Therapeutics, Inc. The name change began with the Nevada Secretary of State...

2014-07-01 08:29:25

One More Planned Step Ahead in the Process of Providing Liquidity to Our Existing Shareholders and Access to Public Capital Markets for the Company NEW YORK, July 1, 2014 /PRNewswire/ -- Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics, Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that has filed a registration statement on Form S-1 with the U.S....

2014-06-16 08:27:58

Relmada Therapeutics and Camp Nine Expect Offering Proceeds to Enable It to Achieve Significant Milestones While Advancing It's Drug Development Pipeline NEW YORK, June 16, 2014 /PRNewswire/ -- Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has completed equity capital raises totaling gross proceeds...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'